Recombinetics is a St. Paul, Minnesota-based bio-engineering company.1 The company was founded in 2008, and has since raised $31 million from private investors. Mark Platt is the CEO.2
In November 2024, Recombinetics filed for Chapter 11 bankruptcy protection. The company has plans to be acquired by Trans Ova Genetics for $4.1 million.3
Products
It is known for developing genetically engineered hornless cattle, and is working on growing human organs and tissues in pigs.4 While it created a cow that does not grow horns, during the creation process it also added genes from bacteria that could produce antibiotic resistance.5 This occurred despite the CEO claiming that they had proof there were no other effects than the horns not being present.5 Due to the bacterial DNA, it is unlikely that the animals will get FDA approval, and a number of them have been killed and the bodies burned.5
References
References
- Schaust, Sam (1 May 2017). "Recombinetics Raises $7M, Hints at Bigger Funding Efforts Ahead". Twin Cities Business. Archived from the original on 2017-05-01. Retrieved 27 September 2017.
- "Recombinetics Announces New Chief Executive Officer". businesswire.com. 2019-02-11. Retrieved 2020-08-12.
- Stefanescu, Victor (November 13, 2024). "Recombinetics, which engineered hornless dairy bulls, files for bankruptcy". Star Tribune. Retrieved November 13, 2024.
- Pettitt, Jeniece (9 September 2017). "These pigs are helping researchers find cures for cancer, and could someday grow human organs". CNBC. Retrieved 27 September 2017.
- Regalado, Antonio. "Gene-edited cattle have a major screwup in their DNA". MIT Technology Review. Retrieved 31 August 2019.